期刊文献+

乌拉地尔降压作用及逆转左室不良重塑的研究 被引量:5

A study of the effect of urapidil in decreasing blood pressure and reversing bad left ventricular remodelling
原文传递
导出
摘要 目的观察乌拉地尔降压及改善心功能与逆转左室不良重塑的作用。方法选择存在左心室肥厚 级、 级高血压患者 6 0例 ,对其服用乌拉地尔前后记录 2 4小时动态血压 ( 2 4ABP) ;测左室收缩、舒张功能及室间隔厚度、左室后壁厚度 ( LVPWD)、左室重量指数( L VMI)进行对比分析。结果 2 4小时平均收缩压及舒张压 ( 2 4MSP和 2 4MDP) ,白昼、夜间平均收缩压及舒张 ( d MSP,MPD;n MSP,n MDP)压均明显下降 ( P<0 .0 1) ;降压谷 /峰比值均大于 6 0 % ;LVMI下降 ( P<0 .0 1) ) ;左室舒张功能有显著改善 ,左室收缩功能改善较小 ( P<0 .0 0 1,P>0 .0 5 )。结论乌拉地尔降压疗效可靠 ,对改善左室舒张功能与逆转左室不良重塑有明显作用 ;副作用小 。 Objective To observe the effect of urapidil in decreasing blood pressure,improving cardiac function and reversing bad left ventricular remodelling.Methods 60 patients with Ⅱ and Ⅲ grade hypertension as well as left ventricular hypertrophy were chosen to record ambulatory blood pressure before and after being given urapidil.The left ventricular systolic and diastolic function,interventricular septal thickness (IVST),left ventricular posterior wall thickness (LVPWT) and left ventricular mass index (LVMI) were measured for comparison.Results 24h mean systolic pressure (MSP),24h mean diastolic pressure (MDP),dMSP,dMDP,and nMSP as well as nMDP were decreased(P<0.01).The trough to peak ratios of systolic and diastolic blood pressures was all above 60%.The LVMI was decreased significantly(P>0.05).The left ventricular diastolic function was improved greatly(P<0.01), but there was no significant change in diastolic function.Conclusion Urapidil is reliable in the treatment of hypertension and effective in the improvement of the left ventricular systolic function and reversal of bad left ventricular remodelling,with little side effects,which can be used for the hypertension at every stage.
出处 《中国综合临床》 北大核心 2002年第1期24-25,共2页 Clinical Medicine of China
关键词 乌拉地尔 动态血压 左室重塑 高血压 降压药 Urapidil Ambulatory blood pressure Left ventricular remodelling Hypertension
  • 相关文献

参考文献1

二级参考文献7

共引文献16

同被引文献28

  • 1时兢,谢卫星,喻立新,许琴芬.乌拉地尔治疗冠心病并发心力衰竭近期疗效观察[J].现代诊断与治疗,2006,17(1):47-48. 被引量:2
  • 2Dimichele JM,Meggs WJ,Semplicini A,et al.Nifedipine for hypertensive emergencies[J].JAMA,1997,277(10):787.
  • 3Kirsten R,Neison R,Kirsten D,et al.Clinical pharmacokinetics of wasodilators[J].Clin phamacokinet.1998,35:9.
  • 4Alijotas-Reig J,Bove-Farre Ⅰ,de Cabo-Frances F,et al.Effectiveness and safety of prehospital urapidil for hypertensive emergencies[J].Am J Emerg Med,2001,19(2):130.
  • 5Wasson S,Fleming D,Reddy HK.Evidence-based drug treatment of heart failure[J].Mo Med,2005,102(6):540;quiz 548.
  • 6Kranke P,Eberhart LH,Roewer N,et al.Single-dose parenteral pharmacological interventions for the prevention of postoperative shivering:a quantitative systematic review of randomized controlled trials[J].Anesth Analg,2004,99(3):718.
  • 7Stangl K,Dschietzig T,Richter C,et al.Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure:acute effects of vasodilator therapy[J].Circulation,2000,102(10):1132.
  • 8郑德裕.高血压病治疗的现代观点[J].中国循环杂志,1997,12(2):81-83. 被引量:26
  • 9刘梅林,张钧华,熊辉,汪波,李大元,邵耕.乌拉地尔对心力衰竭患者的血液动力学效应[J].中华心血管病杂志,1997,25(5):359-361. 被引量:66
  • 10沈炳权,马骥.压宁定治疗高血压急诊38例临床观察[J].急诊医学,1998,7(1):57-58. 被引量:13

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部